Global Viral Detection Market Growth (Status and Outlook) 2026-2032

May 2026 | 129 pages | ID: GF9C40108279EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Viral Detection market size is predicted to grow from US$ 888 million in 2025 to US$ 2479 million in 2032; it is expected to grow at a CAGR of 15.9% from 2026 to 2032.

Viral Detection refers to viral safety testing services performed for biologics, vaccines, recombinant proteins, monoclonal antibodies, cell therapies, gene therapies, as well as their raw materials, cell banks, virus seed stocks, unprocessed bulk harvests, and final product lots. It is not a single physical device; rather, it is an integrated quality-control service package composed of testing strategies, standard operating procedures, sample receipt and preparation workflows, indicator cell lines, nucleic-acid amplification systems, sequencing platforms, electron microscopy platforms, reference controls, data-analysis pipelines, and compliant reporting. Its major categories include cell-based in vitro assays, molecular methods such as PCR, qPCR, and ddPCR, broad-range NGS screening, TEM-based morphological identification, and dedicated assays for replication-competent AAV, replication-competent lentivirus, retroviruses, and related viral risks. The technical principle is to identify known or unknown viral contaminants in different sample matrices through viral growth effects, characteristic nucleic-acid sequences, particle morphology, host-range response, and orthogonal confirmation, then determine whether exogenous viral introduction or amplification risks exist in the manufacturing process. This service is mainly provided by CROs, contract testing laboratories, CDMOs with in-house quality platforms, and specialized biologics safety testing organizations. Its key technical requirements focus on sensitivity, specificity, coverage breadth, sample compatibility, contamination control, regulatory compliance, and robust GMP/GLP system execution. Typical use scenarios include cell bank release, raw material release, in-process control, unprocessed bulk testing, final lot release, and contamination investigation.

The expansion of the Viral Detection market is primarily driven by the continued growth of biologics, cell therapies, gene therapies, and novel vaccines. As product complexity rises, a single analytical method is no longer sufficient to cover all viral-risk scenarios, which is accelerating the combined use of cell-based assays, molecular methods, NGS, and electron microscopy. At the same time, updated regulatory frameworks such as ICH Q5A(R2) are bringing risk-based strategies, sample-tiering logic, animal-free alternatives, and faster release concepts to the forefront, pushing Viral Detection from a ?pre-submission compliance task? toward a continuous quality system spanning cell banking, raw materials, process control, lot release, and deviation investigation. For downstream users, building an internal high-grade viral safety platform requires heavy capital, long validation timelines, and difficult maintenance; therefore, outsourcing to specialized organizations with GMP/GLP systems, established methods, and regulatory communication experience has become a practical route to improve efficiency, shorten timelines, and reduce compliance risk.

The main market challenge is no longer whether testing is required, but how to balance accuracy, coverage, speed, cost, and regulatory acceptance. Traditional in vitro and in vivo assays provide broad coverage, but their timelines are longer and sample compatibility can be limited. PCR-based methods are fast and sensitive, but they do not fully address unknown viral threats. NGS is growing rapidly, yet it places higher demands on data interpretation, background-noise control, contamination tracing, method validation, and cross-batch consistency. In cell and gene therapy, complex sample matrices, vector-related signals, and specialized replication-competent virus risks further increase the difficulty of method development and orthogonal confirmation. The industry also faces practical constraints such as cross-region regulatory differences, scheduling bottlenecks, limited expert capacity, and high biosafety requirements. Future competition will therefore center not only on the number of tests offered, but also on platform strength, regulatory alignment, turnaround time, and investigation capability.

Downstream demand is shifting from isolated testing items toward lifecycle-wide testing portfolios. Historically, demand was concentrated on foundational release testing for cell banks and raw materials. Now, more programs are moving Viral Detection upstream into vector construction, donor-material screening, process monitoring, and contamination root-cause tracing, while also extending it downstream into commercial-stage ongoing quality surveillance. Monoclonal antibodies, recombinant proteins, and vaccines remain the most stable demand base, whereas cell therapies, viral vectors, RNA therapeutics, and complex bioprocesses represent the most elastic sources of incremental demand. Supplier selection is also evolving: customers are looking beyond price and increasingly prioritizing integrated capabilities that combine risk assessment, method development, GMP testing, deviation investigation, and global filing support. This will continue to push the market toward platformization, globalization, and higher-value services.

LPI (LP Information)' newest research report, the ?Viral Detection Industry Forecast? looks at past sales and reviews total world Viral Detection sales in 2025, providing a comprehensive analysis by region and market sector of projected Viral Detection sales for 2026 through 2032. With Viral Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Viral Detection industry.

This Insight Report provides a comprehensive analysis of the global Viral Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Viral Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Viral Detection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Viral Detection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Viral Detection.

This report presents a comprehensive overview, market shares, and growth opportunities of Viral Detection market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • Plaque Assays
  • PCR
  • ELISA
  • Others
Segmentation by Service Delivery Format:
  • Standard Testing Services
  • Customized Method Development Services
  • Validation Services
  • Batch Release Testing Services
  • Investigation Services
  • Others
Segmentation by Sample Matrix:
  • Raw Materials
  • Cell Banks
  • Viral Seed Stocks / Viral Vectors
  • In-Process Samples
  • Bulk Harvest / Drug Substance
  • Final Product
  • Others
Segmentation by Compliance Level:
  • Research Use Only
  • Non-GLP / Non-GMP Testing
  • GLP-compliant Testing
  • GMP-compliant Testing
  • Regulatory Submission Support Testing
  • Others
Segmentation by Application:
  • Blood & Blood Products
  • Cellular & Gene Therapy Products
  • Stem Cell Products
  • Tissue & Tissue Products
  • Vaccines and Therapeutics
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Merck KGaA
  • Charles River Laboratories
  • Eurofins
  • SGS
  • Sartorius
  • Asahi Kasei
  • Samsung Biologics
  • Syngene
  • Intertek
  • Minaris Advanced Therapies
  • Texcell
  • PathoQuest
  • Clean Cells
  • Avance Biosciences
  • Microbiologics
  • Alcami
  • Creative Biolabs
  • Creative Biogene
  • WuXi AppTec
  • WuXi Biologics
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Viral Detection Market Size (2021-2032)
  2.1.2 Viral Detection Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Viral Detection by Country/Region (2021, 2025 & 2032)
2.2 Viral Detection Segment by Type
  2.2.1 Plaque Assays
  2.2.2 PCR
  2.2.3 ELISA
  2.2.4 Others
  2.2.5 Viral Detection Market Size by Type
    2.2.5.1 Viral Detection Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.5.2 Global Viral Detection Market Size Market Share by Type (2021-2026)
2.3 Viral Detection Segment by Service Delivery Format
  2.3.1 Standard Testing Services
  2.3.2 Customized Method Development Services
  2.3.3 Validation Services
  2.3.4 Batch Release Testing Services
  2.3.5 Investigation Services
  2.3.6 Others
  2.3.7 Viral Detection Market Size by Service Delivery Format
    2.3.7.1 Viral Detection Market Size CAGR by Service Delivery Format (2021 VS 2025 VS 2032)
    2.3.7.2 Global Viral Detection Market Size Market Share by Service Delivery Format (2021-2026)
2.4 Viral Detection Segment by Sample Matrix
  2.4.1 Raw Materials
  2.4.2 Cell Banks
  2.4.3 Viral Seed Stocks / Viral Vectors
  2.4.4 In-Process Samples
  2.4.5 Bulk Harvest / Drug Substance
  2.4.6 Final Product
  2.4.7 Others
  2.4.8 Viral Detection Market Size by Sample Matrix
    2.4.8.1 Viral Detection Market Size CAGR by Sample Matrix (2021 VS 2025 VS 2032)
    2.4.8.2 Global Viral Detection Market Size Market Share by Sample Matrix (2021-2026)
2.5 Viral Detection Segment by Compliance Level
  2.5.1 Research Use Only
  2.5.2 Non-GLP / Non-GMP Testing
  2.5.3 GLP-compliant Testing
  2.5.4 GMP-compliant Testing
  2.5.5 Regulatory Submission Support Testing
  2.5.6 Others
  2.5.7 Viral Detection Market Size by Compliance Level
    2.5.7.1 Viral Detection Market Size CAGR by Compliance Level (2021 VS 2025 VS 2032)
    2.5.7.2 Global Viral Detection Market Size Market Share by Compliance Level (2021-2026)
2.6 Viral Detection Segment by Application
  2.6.1 Blood & Blood Products
  2.6.2 Cellular & Gene Therapy Products
  2.6.3 Stem Cell Products
  2.6.4 Tissue & Tissue Products
  2.6.5 Vaccines and Therapeutics
  2.6.6 Viral Detection Market Size by Application
    2.6.6.1 Viral Detection Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.6.6.2 Global Viral Detection Market Size Market Share by Application (2021-2026)

3 VIRAL DETECTION MARKET SIZE BY PLAYER

3.1 Viral Detection Market Size Market Share by Player
  3.1.1 Global Viral Detection Revenue by Player (2021-2026)
  3.1.2 Global Viral Detection Revenue Market Share by Player (2021-2026)
3.2 Global Viral Detection Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 VIRAL DETECTION BY REGION

4.1 Viral Detection Market Size by Region (2021-2026)
4.2 Global Viral Detection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Viral Detection Market Size Growth (2021-2026)
4.4 APAC Viral Detection Market Size Growth (2021-2026)
4.5 Europe Viral Detection Market Size Growth (2021-2026)
4.6 Middle East & Africa Viral Detection Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Viral Detection Market Size by Country (2021-2026)
5.2 Americas Viral Detection Market Size by Type (2021-2026)
5.3 Americas Viral Detection Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Viral Detection Market Size by Region (2021-2026)
6.2 APAC Viral Detection Market Size by Type (2021-2026)
6.3 APAC Viral Detection Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Viral Detection Market Size by Country (2021-2026)
7.2 Europe Viral Detection Market Size by Type (2021-2026)
7.3 Europe Viral Detection Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Viral Detection by Region (2021-2026)
8.2 Middle East & Africa Viral Detection Market Size by Type (2021-2026)
8.3 Middle East & Africa Viral Detection Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL VIRAL DETECTION MARKET FORECAST

10.1 Global Viral Detection Forecast by Region (2027-2032)
  10.1.1 Global Viral Detection Forecast by Region (2027-2032)
  10.1.2 Americas Viral Detection Forecast
  10.1.3 APAC Viral Detection Forecast
  10.1.4 Europe Viral Detection Forecast
  10.1.5 Middle East & Africa Viral Detection Forecast
10.2 Americas Viral Detection Forecast by Country (2027-2032)
  10.2.1 United States Market Viral Detection Forecast
  10.2.2 Canada Market Viral Detection Forecast
  10.2.3 Mexico Market Viral Detection Forecast
  10.2.4 Brazil Market Viral Detection Forecast
10.3 APAC Viral Detection Forecast by Region (2027-2032)
  10.3.1 China Viral Detection Market Forecast
  10.3.2 Japan Market Viral Detection Forecast
  10.3.3 Korea Market Viral Detection Forecast
  10.3.4 Southeast Asia Market Viral Detection Forecast
  10.3.5 India Market Viral Detection Forecast
  10.3.6 Australia Market Viral Detection Forecast
10.4 Europe Viral Detection Forecast by Country (2027-2032)
  10.4.1 Germany Market Viral Detection Forecast
  10.4.2 France Market Viral Detection Forecast
  10.4.3 UK Market Viral Detection Forecast
  10.4.4 Italy Market Viral Detection Forecast
  10.4.5 Russia Market Viral Detection Forecast
10.5 Middle East & Africa Viral Detection Forecast by Region (2027-2032)
  10.5.1 Egypt Market Viral Detection Forecast
  10.5.2 South Africa Market Viral Detection Forecast
  10.5.3 Israel Market Viral Detection Forecast
  10.5.4 Turkey Market Viral Detection Forecast
10.6 Global Viral Detection Forecast by Type (2027-2032)
10.7 Global Viral Detection Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Viral Detection Forecast

11 KEY PLAYERS ANALYSIS

11.1 Merck KGaA
  11.1.1 Merck KGaA Company Information
  11.1.2 Merck KGaA Viral Detection Product Offered
  11.1.3 Merck KGaA Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Merck KGaA Main Business Overview
  11.1.5 Merck KGaA Latest Developments
11.2 Charles River Laboratories
  11.2.1 Charles River Laboratories Company Information
  11.2.2 Charles River Laboratories Viral Detection Product Offered
  11.2.3 Charles River Laboratories Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Charles River Laboratories Main Business Overview
  11.2.5 Charles River Laboratories Latest Developments
11.3 Eurofins
  11.3.1 Eurofins Company Information
  11.3.2 Eurofins Viral Detection Product Offered
  11.3.3 Eurofins Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Eurofins Main Business Overview
  11.3.5 Eurofins Latest Developments
11.4 SGS
  11.4.1 SGS Company Information
  11.4.2 SGS Viral Detection Product Offered
  11.4.3 SGS Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 SGS Main Business Overview
  11.4.5 SGS Latest Developments
11.5 Sartorius
  11.5.1 Sartorius Company Information
  11.5.2 Sartorius Viral Detection Product Offered
  11.5.3 Sartorius Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Sartorius Main Business Overview
  11.5.5 Sartorius Latest Developments
11.6 Asahi Kasei
  11.6.1 Asahi Kasei Company Information
  11.6.2 Asahi Kasei Viral Detection Product Offered
  11.6.3 Asahi Kasei Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Asahi Kasei Main Business Overview
  11.6.5 Asahi Kasei Latest Developments
11.7 Samsung Biologics
  11.7.1 Samsung Biologics Company Information
  11.7.2 Samsung Biologics Viral Detection Product Offered
  11.7.3 Samsung Biologics Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Samsung Biologics Main Business Overview
  11.7.5 Samsung Biologics Latest Developments
11.8 Syngene
  11.8.1 Syngene Company Information
  11.8.2 Syngene Viral Detection Product Offered
  11.8.3 Syngene Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Syngene Main Business Overview
  11.8.5 Syngene Latest Developments
11.9 Intertek
  11.9.1 Intertek Company Information
  11.9.2 Intertek Viral Detection Product Offered
  11.9.3 Intertek Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Intertek Main Business Overview
  11.9.5 Intertek Latest Developments
11.10 Minaris Advanced Therapies
  11.10.1 Minaris Advanced Therapies Company Information
  11.10.2 Minaris Advanced Therapies Viral Detection Product Offered
  11.10.3 Minaris Advanced Therapies Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Minaris Advanced Therapies Main Business Overview
  11.10.5 Minaris Advanced Therapies Latest Developments
11.11 Texcell
  11.11.1 Texcell Company Information
  11.11.2 Texcell Viral Detection Product Offered
  11.11.3 Texcell Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 Texcell Main Business Overview
  11.11.5 Texcell Latest Developments
11.12 PathoQuest
  11.12.1 PathoQuest Company Information
  11.12.2 PathoQuest Viral Detection Product Offered
  11.12.3 PathoQuest Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.12.4 PathoQuest Main Business Overview
  11.12.5 PathoQuest Latest Developments
11.13 Clean Cells
  11.13.1 Clean Cells Company Information
  11.13.2 Clean Cells Viral Detection Product Offered
  11.13.3 Clean Cells Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.13.4 Clean Cells Main Business Overview
  11.13.5 Clean Cells Latest Developments
11.14 Avance Biosciences
  11.14.1 Avance Biosciences Company Information
  11.14.2 Avance Biosciences Viral Detection Product Offered
  11.14.3 Avance Biosciences Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.14.4 Avance Biosciences Main Business Overview
  11.14.5 Avance Biosciences Latest Developments
11.15 Microbiologics
  11.15.1 Microbiologics Company Information
  11.15.2 Microbiologics Viral Detection Product Offered
  11.15.3 Microbiologics Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.15.4 Microbiologics Main Business Overview
  11.15.5 Microbiologics Latest Developments
11.16 Alcami
  11.16.1 Alcami Company Information
  11.16.2 Alcami Viral Detection Product Offered
  11.16.3 Alcami Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.16.4 Alcami Main Business Overview
  11.16.5 Alcami Latest Developments
11.17 Creative Biolabs
  11.17.1 Creative Biolabs Company Information
  11.17.2 Creative Biolabs Viral Detection Product Offered
  11.17.3 Creative Biolabs Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.17.4 Creative Biolabs Main Business Overview
  11.17.5 Creative Biolabs Latest Developments
11.18 Creative Biogene
  11.18.1 Creative Biogene Company Information
  11.18.2 Creative Biogene Viral Detection Product Offered
  11.18.3 Creative Biogene Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.18.4 Creative Biogene Main Business Overview
  11.18.5 Creative Biogene Latest Developments
11.19 WuXi AppTec
  11.19.1 WuXi AppTec Company Information
  11.19.2 WuXi AppTec Viral Detection Product Offered
  11.19.3 WuXi AppTec Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.19.4 WuXi AppTec Main Business Overview
  11.19.5 WuXi AppTec Latest Developments
11.20 WuXi Biologics
  11.20.1 WuXi Biologics Company Information
  11.20.2 WuXi Biologics Viral Detection Product Offered
  11.20.3 WuXi Biologics Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.20.4 WuXi Biologics Main Business Overview
  11.20.5 WuXi Biologics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION



LIST OF TABLES

Table 1. Viral Detection Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Viral Detection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Plaque Assays
Table 4. Major Players of PCR
Table 5. Major Players of ELISA
Table 6. Major Players of Others
Table 7. Viral Detection Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Viral Detection Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Viral Detection Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Standard Testing Services
Table 11. Major Players of Customized Method Development Services
Table 12. Major Players of Validation Services
Table 13. Major Players of Batch Release Testing Services
Table 14. Major Players of Investigation Services
Table 15. Major Players of Others
Table 16. Viral Detection Market Size CAGR by Service Delivery Format (2021 VS 2025 VS 2032) & ($ millions)
Table 17. Global Viral Detection Market Size by Service Delivery Format (2021-2026) & ($ millions)
Table 18. Global Viral Detection Market Size Market Share by Service Delivery Format (2021-2026)
Table 19. Major Players of Raw Materials
Table 20. Major Players of Cell Banks
Table 21. Major Players of Viral Seed Stocks / Viral Vectors
Table 22. Major Players of In-Process Samples
Table 23. Major Players of Bulk Harvest / Drug Substance
Table 24. Major Players of Final Product
Table 25. Major Players of Others
Table 26. Viral Detection Market Size CAGR by Sample Matrix (2021 VS 2025 VS 2032) & ($ millions)
Table 27. Global Viral Detection Market Size by Sample Matrix (2021-2026) & ($ millions)
Table 28. Global Viral Detection Market Size Market Share by Sample Matrix (2021-2026)
Table 29. Major Players of Research Use Only
Table 30. Major Players of Non-GLP / Non-GMP Testing
Table 31. Major Players of GLP-compliant Testing
Table 32. Major Players of GMP-compliant Testing
Table 33. Major Players of Regulatory Submission Support Testing
Table 34. Major Players of Others
Table 35. Viral Detection Market Size CAGR by Compliance Level (2021 VS 2025 VS 2032) & ($ millions)
Table 36. Global Viral Detection Market Size by Compliance Level (2021-2026) & ($ millions)
Table 37. Global Viral Detection Market Size Market Share by Compliance Level (2021-2026)
Table 38. Viral Detection Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 39. Global Viral Detection Market Size by Application (2021-2026) & ($ millions)
Table 40. Global Viral Detection Market Size Market Share by Application (2021-2026)
Table 41. Global Viral Detection Revenue by Player (2021-2026) & ($ millions)
Table 42. Global Viral Detection Revenue Market Share by Player (2021-2026)
Table 43. Viral Detection Key Players Head office and Products Offered
Table 44. Viral Detection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Mergers & Acquisitions, Expansion
Table 47. Global Viral Detection Market Size by Region (2021-2026) & ($ millions)
Table 48. Global Viral Detection Market Size Market Share by Region (2021-2026)
Table 49. Global Viral Detection Revenue by Country/Region (2021-2026) & ($ millions)
Table 50. Global Viral Detection Revenue Market Share by Country/Region (2021-2026)
Table 51. Americas Viral Detection Market Size by Country (2021-2026) & ($ millions)
Table 52. Americas Viral Detection Market Size Market Share by Country (2021-2026)
Table 53. Americas Viral Detection Market Size by Type (2021-2026) & ($ millions)
Table 54. Americas Viral Detection Market Size Market Share by Type (2021-2026)
Table 55. Americas Viral Detection Market Size by Application (2021-2026) & ($ millions)
Table 56. Americas Viral Detection Market Size Market Share by Application (2021-2026)
Table 57. APAC Viral Detection Market Size by Region (2021-2026) & ($ millions)
Table 58. APAC Viral Detection Market Size Market Share by Region (2021-2026)
Table 59. APAC Viral Detection Market Size by Type (2021-2026) & ($ millions)
Table 60. APAC Viral Detection Market Size by Application (2021-2026) & ($ millions)
Table 61. Europe Viral Detection Market Size by Country (2021-2026) & ($ millions)
Table 62. Europe Viral Detection Market Size Market Share by Country (2021-2026)
Table 63. Europe Viral Detection Market Size by Type (2021-2026) & ($ millions)
Table 64. Europe Viral Detection Market Size by Application (2021-2026) & ($ millions)
Table 65. Middle East & Africa Viral Detection Market Size by Region (2021-2026) & ($ millions)
Table 66. Middle East & Africa Viral Detection Market Size by Type (2021-2026) & ($ millions)
Table 67. Middle East & Africa Viral Detection Market Size by Application (2021-2026) & ($ millions)
Table 68. Key Market Drivers & Growth Opportunities of Viral Detection
Table 69. Key Market Challenges & Risks of Viral Detection
Table 70. Key Industry Trends of Viral Detection
Table 71. Global Viral Detection Market Size Forecast by Region (2027-2032) & ($ millions)
Table 72. Global Viral Detection Market Size Market Share Forecast by Region (2027-2032)
Table 73. Global Viral Detection Market Size Forecast by Type (2027-2032) & ($ millions)
Table 74. Global Viral Detection Market Size Forecast by Application (2027-2032) & ($ millions)
Table 75. Merck KGaA Details, Company Type, Viral Detection Area Served and Its Competitors
Table 76. Merck KGaA Viral Detection Product Offered
Table 77. Merck KGaA Viral Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Merck KGaA Main Business
Table 79. Merck KGaA Latest Developments
Table 80. Charles River Laboratories Details, Company Type, Viral Detection Area Served and Its Competitors
Table 81. Charles River Laboratories Viral Detection Product Offered
Table 82. Charles River Laboratories Viral Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Charles River Laboratories Main Business
Table 84. Charles River Laboratories Latest Developments
Table 85. Eurofins Details, Company Type, Viral Detection Area Served and Its Competitors
Table 86. Eurofins Viral Detection Product Offered
Table 87. Eurofins Viral Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Eurofins Main Business
Table 89. Eurofins Latest Developments
Table 90. SGS Details, Company Type, Viral Detection Area Served and Its Competitors
Table 91. SGS Viral Detection Product Offered
Table 92. SGS Viral Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. SGS Main Business
Table 94. SGS Latest Developments
Table 95. Sartorius Details, Company Type, Viral Detection Area Served and Its Competitors
Table 96. Sartorius Viral Detection Product Offered
Table 97. Sartorius Viral Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Sartorius Main Business
Table 99. Sartorius Latest Developments
Table 100. Asahi Kasei Details, Company Type, Viral Detection Area Served and Its Competitors
Table 101. Asahi Kasei Viral Detection Product Offered
Table 102. Asahi Kasei Viral Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Asahi Kasei Main Business
Table 104. Asahi Kasei Latest Developments
Table 105. Samsung Biologics Details, Company Type, Viral Detection Area Served and Its Competitors
Table 106. Samsung Biologics Viral Detection Product Offered
Table 107. Samsung Biologics Viral Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Samsung Biologics Main Business
Table 109. Samsung Biologics Latest Developments
Table 110. Syngene Details, Company Type, Viral Detection Area Served and Its Competitors
Table 111. Syngene Viral Detection Product Offered
Table 112. Syngene Viral Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Syngene Main Business
Table 114. Syngene Latest Developments
Table 115. Intertek Details, Company Type, Viral Detection Area Served and Its Competitors
Table 116. Intertek Viral Detection Product Offered
Table 117. Intertek Viral Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Intertek Main Business
Table 119. Intertek Latest Developments
Table 120. Minaris Advanced Therapies Details, Company Type, Viral Detection Area Served and Its Competitors
Table 121. Minaris Advanced Therapies Viral Detection Product Offered
Table 122. Minaris Advanced Therapies Viral Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Minaris Advanced Therapies Main Business
Table 124. Minaris Advanced Therapies Latest Developments
Table 125. Texcell Details, Company Type, Viral Detection Area Served and Its Competitors
Table 126. Texcell Viral Detection Product Offered
Table 127. Texcell Viral Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Texcell Main Business
Table 129. Texcell Latest Developments
Table 130. PathoQuest Details, Company Type, Viral Detection Area Served and Its Competitors
Table 131. PathoQuest Viral Detection Product Offered
Table 132. PathoQuest Viral Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. PathoQuest Main Business
Table 134. PathoQuest Latest Developments
Table 135. Clean Cells Details, Company Type, Viral Detection Area Served and Its Competitors
Table 136. Clean Cells Viral Detection Product Offered
Table 137. Clean Cells Viral Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Clean Cells Main Business
Table 139. Clean Cells Latest Developments
Table 140. Avance Biosciences Details, Company Type, Viral Detection Area Served and Its Competitors
Table 141. Avance Biosciences Viral Detection Product Offered
Table 142. Avance Biosciences Viral Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. Avance Biosciences Main Business
Table 144. Avance Biosciences Latest Developments
Table 145. Microbiologics Details, Company Type, Viral Detection Area Served and Its Competitors
Table 146. Microbiologics Viral Detection Product Offered
Table 147. Microbiologics Viral Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 148. Microbiologics Main Business
Table 149. Microbiologics Latest Developments
Table 150. Alcami Details, Company Type, Viral Detection Area Served and Its Competitors
Table 151. Alcami Viral Detection Product Offered
Table 152. Alcami Viral Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 153. Alcami Main Business
Table 154. Alcami Latest Developments
Table 155. Creative Biolabs Details, Company Type, Viral Detection Area Served and Its Competitors
Table 156. Creative Biolabs Viral Detection Product Offered
Table 157. Creative Biolabs Viral Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 158. Creative Biolabs Main Business
Table 159. Creative Biolabs Latest Developments
Table 160. Creative Biogene Details, Company Type, Viral Detection Area Served and Its Competitors
Table 161. Creative Biogene Viral Detection Product Offered
Table 162. Creative Biogene Viral Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 163. Creative Biogene Main Business
Table 164. Creative Biogene Latest Developments
Table 165. WuXi AppTec Details, Company Type, Viral Detection Area Served and Its Competitors
Table 166. WuXi AppTec Viral Detection Product Offered
Table 167. WuXi AppTec Viral Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 168. WuXi AppTec Main Business
Table 169. WuXi AppTec Latest Developments
Table 170. WuXi Biologics Details, Company Type, Viral Detection Area Served and Its Competitors
Table 171. WuXi Biologics Viral Detection Product Offered
Table 172. WuXi Biologics Viral Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 173. WuXi Biologics Main Business
Table 174. WuXi Biologics Latest Developments

LIST OF FIGURES

Figure 1. Viral Detection Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Viral Detection Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Viral Detection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Viral Detection Sales Market Share by Country/Region (2025)
Figure 8. Viral Detection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Viral Detection Market Size Market Share by Type in 2025
Figure 10. Global Viral Detection Market Size Market Share by Service Delivery Format in 2025
Figure 11. Global Viral Detection Market Size Market Share by Sample Matrix in 2025
Figure 12. Global Viral Detection Market Size Market Share by Compliance Level in 2025
Figure 13. Viral Detection in Blood & Blood Products
Figure 14. Global Viral Detection Market: Blood & Blood Products (2021-2026) & ($ millions)
Figure 15. Viral Detection in Cellular & Gene Therapy Products
Figure 16. Global Viral Detection Market: Cellular & Gene Therapy Products (2021-2026) & ($ millions)
Figure 17. Viral Detection in Stem Cell Products
Figure 18. Global Viral Detection Market: Stem Cell Products (2021-2026) & ($ millions)
Figure 19. Viral Detection in Tissue & Tissue Products
Figure 20. Global Viral Detection Market: Tissue & Tissue Products (2021-2026) & ($ millions)
Figure 21. Viral Detection in Vaccines and Therapeutics
Figure 22. Global Viral Detection Market: Vaccines and Therapeutics (2021-2026) & ($ millions)
Figure 23. Global Viral Detection Market Size Market Share by Application in 2025
Figure 24. Global Viral Detection Revenue Market Share by Player in 2025
Figure 25. Global Viral Detection Market Size Market Share by Region (2021-2026)
Figure 26. Americas Viral Detection Market Size 2021-2026 ($ millions)
Figure 27. APAC Viral Detection Market Size 2021-2026 ($ millions)
Figure 28. Europe Viral Detection Market Size 2021-2026 ($ millions)
Figure 29. Middle East & Africa Viral Detection Market Size 2021-2026 ($ millions)
Figure 30. Americas Viral Detection Value Market Share by Country in 2025
Figure 31. United States Viral Detection Market Size Growth 2021-2026 ($ millions)
Figure 32. Canada Viral Detection Market Size Growth 2021-2026 ($ millions)
Figure 33. Mexico Viral Detection Market Size Growth 2021-2026 ($ millions)
Figure 34. Brazil Viral Detection Market Size Growth 2021-2026 ($ millions)
Figure 35. APAC Viral Detection Market Size Market Share by Region in 2025
Figure 36. APAC Viral Detection Market Size Market Share by Type (2021-2026)
Figure 37. APAC Viral Detection Market Size Market Share by Application (2021-2026)
Figure 38. China Viral Detection Market Size Growth 2021-2026 ($ millions)
Figure 39. Japan Viral Detection Market Size Growth 2021-2026 ($ millions)
Figure 40. South Korea Viral Detection Market Size Growth 2021-2026 ($ millions)
Figure 41. Southeast Asia Viral Detection Market Size Growth 2021-2026 ($ millions)
Figure 42. India Viral Detection Market Size Growth 2021-2026 ($ millions)
Figure 43. Australia Viral Detection Market Size Growth 2021-2026 ($ millions)
Figure 44. Europe Viral Detection Market Size Market Share by Country in 2025
Figure 45. Europe Viral Detection Market Size Market Share by Type (2021-2026)
Figure 46. Europe Viral Detection Market Size Market Share by Application (2021-2026)
Figure 47. Germany Viral Detection Market Size Growth 2021-2026 ($ millions)
Figure 48. France Viral Detection Market Size Growth 2021-2026 ($ millions)
Figure 49. UK Viral Detection Market Size Growth 2021-2026 ($ millions)
Figure 50. Italy Viral Detection Market Size Growth 2021-2026 ($ millions)
Figure 51. Russia Viral Detection Market Size Growth 2021-2026 ($ millions)
Figure 52. Middle East & Africa Viral Detection Market Size Market Share by Region (2021-2026)
Figure 53. Middle East & Africa Viral Detection Market Size Market Share by Type (2021-2026)
Figure 54. Middle East & Africa Viral Detection Market Size Market Share by Application (2021-2026)
Figure 55. Egypt Viral Detection Market Size Growth 2021-2026 ($ millions)
Figure 56. South Africa Viral Detection Market Size Growth 2021-2026 ($ millions)
Figure 57. Israel Viral Detection Market Size Growth 2021-2026 ($ millions)
Figure 58. Turkey Viral Detection Market Size Growth 2021-2026 ($ millions)
Figure 59. GCC Countries Viral Detection Market Size Growth 2021-2026 ($ millions)
Figure 60. Americas Viral Detection Market Size 2027-2032 ($ millions)
Figure 61. APAC Viral Detection Market Size 2027-2032 ($ millions)
Figure 62. Europe Viral Detection Market Size 2027-2032 ($ millions)
Figure 63. Middle East & Africa Viral Detection Market Size 2027-2032 ($ millions)
Figure 64. United States Viral Detection Market Size 2027-2032 ($ millions)
Figure 65. Canada Viral Detection Market Size 2027-2032 ($ millions)
Figure 66. Mexico Viral Detection Market Size 2027-2032 ($ millions)
Figure 67. Brazil Viral Detection Market Size 2027-2032 ($ millions)
Figure 68. China Viral Detection Market Size 2027-2032 ($ millions)
Figure 69. Japan Viral Detection Market Size 2027-2032 ($ millions)
Figure 70. Korea Viral Detection Market Size 2027-2032 ($ millions)
Figure 71. Southeast Asia Viral Detection Market Size 2027-2032 ($ millions)
Figure 72. India Viral Detection Market Size 2027-2032 ($ millions)
Figure 73. Australia Viral Detection Market Size 2027-2032 ($ millions)
Figure 74. Germany Viral Detection Market Size 2027-2032 ($ millions)
Figure 75. France Viral Detection Market Size 2027-2032 ($ millions)
Figure 76. UK Viral Detection Market Size 2027-2032 ($ millions)
Figure 77. Italy Viral Detection Market Size 2027-2032 ($ millions)
Figure 78. Russia Viral Detection Market Size 2027-2032 ($ millions)
Figure 79. Egypt Viral Detection Market Size 2027-2032 ($ millions)
Figure 80. South Africa Viral Detection Market Size 2027-2032 ($ millions)
Figure 81. Israel Viral Detection Market Size 2027-2032 ($ millions)
Figure 82. Turkey Viral Detection Market Size 2027-2032 ($ millions)
Figure 83. Global Viral Detection Market Size Market Share Forecast by Type (2027-2032)
Figure 84. Global Viral Detection Market Size Market Share Forecast by Application (2027-2032)
Figure 85. GCC Countries Viral Detection Market Size 2027-2032 ($ millions)